Relevance of intraocular involvement in the management of primary central nervous system lymphomas

Annals of Oncology

Volumn 13, Issue 4, 2002, Pages 531-538

  Ferreri, A J M ^a   Blay, J Y ^a   Reni, M ^a   Pasini, F ^a   Gubkin, A ^a   Tirelli, U ^a   Calderoni, A ^a   Zucca, E ^a   Cortelazzo, S ^a   Chassagne, C ^a   Tinguely, M ^a   Borisch, B ^a   Berger, F ^a   Ponzoni, M ^a   Cavalli, F ^a   Biron, Pierre ^a   Ambrosetti, Achille ^a   Iuzzolino, Paolo ^a   Chevreau, Christine ^a   Vavassori, Vittorio ^a   Cerati, Michele ^a   Eghbali, Houchingue ^a   Bouabdallah, Reda ^a   Conroy, Thierry ^a   Spina, Michele ^a   Carbone, Antonino ^a   Joachim, Weis ^a   Dramais Marcel, Dominique ^a   Rossi, Andrea ^a   Barbui, Tiziano ^a   Motta, Teresio ^a   Pivnik, Alexander ^a   Conconi, Annarita ^a   Pedrinis, Ennio ^a   Aondio, Gian Marco ^a   Milani, Mario ^a   Philippe, Jean ^a   Le Mevel, Anne Marie ^a   Orvieto, Enrico ^a   Ferrarese, Fabio ^a   Gomez, Henry ^a   Sanchez, Juvenal ^a   Jouvet, Anne ^a   Coiffier, Bertrand ^a   Baumelou, Elisabeth ^a   Thyss, Antonie ^a   Devizzi, Liliana ^a   Dell'Oro, Stefania ^a   more..

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Chemotherapy; Combined treatment; Eye; Intraocular lymphoma; Ocular irradiation; Primary central nervous system lymphoma

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; NITROSOUREA; PREDNISONE; PROCARBAZINE; THIOTEPA; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN LYMPHOMA; BRAIN RADIATION; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG MEGADOSE; EYE CANCER; FEMALE; HUMAN; IMMUNOCOMPETENCE; MALE; MENINX DISORDER; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SLIT LAMP; SYMPTOMATOLOGY; TREATMENT FAILURE; TREATMENT PLANNING;

EID: 0036234083     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdf080     Document Type: Article

References (33)

1. Primary CNS lymphoma: Combined treatment with chemotherapy and radiotherapy
2. Primary central nervous system lymphoma in immunocompetent patients
3. A single-center study of 11 patients with intraocular lymphoma treated with conventional chemotherapy followed by high-dose chemotherapy and autologous bone marrow transplantation in five cases
4. Intraocular-central nervous system lymphoma: Clinical features, diagnosis, and outcomes
5. Combined malignant lymphoma of the eye and CNS (reticulum-cell sarcoma). Report of three cases
6. Intraocular lymphomas. Natural history based on a clinicopathologic study of eight cases and review of the literature
7. The clinical spectrum of ocular lymphoma
8. Ocular and central nervous system lymphoma: Clinical features and diagnosis
9. Ophthalmic, ultrasonographic findings in primary central nervous system lymphoma with ocular involvement
10. Primary central nervous system lymphoma
11. Intraocular lymphoma: Immunological and cytological analysis
12. Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma
13. Primary central nervous system lymphoma
14. Intraocular lymphoma. Clinical and histopathologic diagnosis
15. Ten-year experience with primary ocular 'reticulum cell sarcoma' (large cell non-Hodgkin's lymphoma)
16. Treatment of intraocular lymphoma with high-dose Ara-C
17. Chemotherapy in the management of intraocular lymphoma
18. Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma
19. Intraocular methotrexate level after high-dose intravenous infusion
20. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project
21. Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma
22. Intraocular lymphoma. Immunopathologic analysis of vitreous biopsy specimens
23. Improving the diagnostic yield of vitrectomy for intraocular lymphoma
24. Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: Initial report of Radiation Therapy Oncology Group Protocol 88-06
25. The C5R protocol: A regimen of high-dose chemotherapy and radiotherapy in primary cerebral non-Hodgkin's lymphoma of patients with no known cause of immunosuppression
26. Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: Long-term outcome
27. Combination chemotherapy in the treatment of primary central nervous system and intraocular lymphoma
28. Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma
29. Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma
30. High-dose methotrexate for non-AIDS primary central nervous system lymphoma. Report of 13 cases
31. Primary central nervous system lymphoma: Treatment with chemotherapy and radiotherapy
32. Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy
33. Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients